/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Patient-reported treatment burden: comparison between vitamin-K antagonist and non-vitamin K antagonist oral anticoagulants
Event: EHRA 2024
Topic: Oral Anticoagulation
Session: Poster session on devices, others
Sex-related differences in self-reported treatment burden in patients with atrial fibrillation
Event: EHRA 2021
Topic: Treatment
Session: ePoster session
Main determinants of physician-driven amiodarone discontinuation in clinical practice
Event: EHRA 2021
Topic: Antiarrhythmic Drug Treatment
Session: New approaches for ablation
Amiodarone in contemporary clinical practice: the rates of and reasons for permanent drug discontinuation
Event: ESC Congress 2019
Topic: Antiarrhythmic Pharmacotherapy
Session: Anti-arrhythmic drug therapy: new concepts on old drugs
Amiodarone treatment duration and reasons for permanent drug discontinuation in patients with atrial fibrillation
Event: ESC Congress 2019
Topic: Rhythm Control, Antiarrhythmic Drugs
Session: Drug treatment for atrial fibrillation
ESC 365 is supported by
